WHO ICTRP trial
EMBrACe – Patient empowerment through competence: reaching for health beyond the…
DRKS00032098 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00032098 |
|---|---|
| Public title | EMBrACe – Patient empowerment through competence: reaching for health beyond the absence of cancer. |
| Scientific title | EMBrACe – Patient empowerment through competence: reaching for health beyond the absence of cancer. - EMBrACe |
| Primary sponsor | Universitätsklinikum Köln |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Germany |
| Conditions | C81;Hodgkin lymphoma |
| Interventions | Group 1: Arm A (control group): Limited access to the EMBrACe platform, including links to the GSHG homepage and other pre-existing websites, from HL initial diagnosis up to one year after first-line therapy. Group 2: Arm B (intervention… |
| Registration date | Jun 19, 2023 |
| Target size | 300 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: